In studies of murine infection, the capsule thickness of Cryptococcus neoformans varied depending on the organ. The relative order of thickness was as follows: lung > brain > in vitro isolates. The differences in capsule thickness suggest that there are organ-related differences in the expression of genes responsible for capsule thickness.
Capsule dimensions in organ homogenates and cultures were measured. Twenty microliters of MAb-stained (18) brain or lung homogenate was placed on a slide with 20 l of 1% Uvitex 3BSA-PBS (Ciba-Geigy, Greensboro, N.C.). Coverslips were applied, and a small drop of India ink (Difco Laboratories) was added. The slides were viewed with an Olympus IX 70 microscope (Olympus America, Inc., Melville, N.Y.) with ϫ60 numerical aperture. 1.4 optics equipped with standard fluorescein isothiocyanate and 4Ј,6-diamidino-2-phenylindole (DAPI) filters. Images were collected with a Photometrics KAF 1400-cooled, charge-coupled device camera (Tucson, Ariz.) on a Power Macintosh 8500 (Apple Computer, Austin, Tex.) with I. P. Lab Spectrum software (Scanalytics, Fairfax, Va.). The thickness of the C. neoformans capsule and cell body was measured by tracing the circumference of the whole organism and cell body at the equatorial plane. Calculations of area and volume were partially automated by using macros written within the public-domain software NIH-Image (National Institutes of Health, Bethesda, Md.). All data were analyzed by the Student t test and the Kruskal-Wallis test (Primer; McGrawHill, Inc., New York, N.Y.). P values of Ͻ0.05 were considered significant.
Uvitex 3BSA binds chitin in the yeast cell wall (14) and was used to delineate the cell wall. The outer boundary of the capsule was established by combining India ink staining and indirect immunofluorescence with GXM-specific MAbs (Fig.  1B) . To determine if India ink or MAb altered capsule thickness, yeast cells were suspended in India ink with Uvitex 3BSA and in MAb with Uvitex 3BSA. Measurements of capsule thickness were the same in both instances (data not shown). To determine if the tissue homogenate influenced capsule thickness, yeast cells were suspended and cultured in brain and lung homogenates of noninfected mice. Capsule thickness did not change (data not shown).
C. neoformans cells, which were grown in vitro and used for initial infection, had an average capsule thickness of 2.8 Ϯ 1.4 m. Yeast cells in tissue homogenates had significantly larger capsules, with an average capsule thickness among lung organisms of 20.0 Ϯ 6.1 m, whereas organisms isolated from the brain had an average capsule thickness of 8.4 Ϯ 3.9 m (Fig. 2) (P Ͻ 0.001). Uvitex 3BSA and MAb 2H1 staining revealed differences in the capsule thicknesses of organisms in lung and brain tissues and in vitro (Fig. 3) . In addition, organisms isolated from the lungs of SCID/NCr and BALB/c mice had average capsule thicknesses of 18.5 Ϯ 8.3 m and 17.9 Ϯ 7.6 m, respectively (P ϭ 0.648). The average capsule volumes for organisms in lung and brain tissues and under in vitro condi-tions were 1.1 ϫ 10 5 Ϯ 6.6 ϫ 10 4 m 3 , 1.7 ϫ 10 4 Ϯ 2.7 ϫ 10 4 m 3 , and 3.3 ϫ 10 3 Ϯ 1.7 ϫ 10 3 m 3 , respectively. To explore whether the differences in capsule thickness reflected inherent characteristics of yeast cells in these tissues or a response to the tissue environment, mice were infected with C. neoformans recovered from brain and lung homogenates. Yeast cells from mice infected with isolates recovered from lung homogenates again had capsules in the lung that were significantly larger than those in the brain (P Ͻ 0.001) (Fig. 2) . In addition, yeast cells from mice infected with isolates recovered from brain homogenates had capsules in the lung that were significantly larger than those in the brain (P Ͻ 0.001) (Fig. 2) . Hence, the changes in capsule thickness were reversible. Organisms isolated from the brain and lung had the same average capsule thickness when they were grown in vitro (Fig.  2) . Despite the source of the isolate used for infection, the relative order of capsule thickness was as follows: lung Ͼ brain Ͼ in vitro-grown isolates. The concentrations of polysaccharide in brain and lung tissues were 8.8 ϫ 10 Ϫ1 Ϯ 1.0 g/CFU and 1.8 ϫ 10 Ϫ3 Ϯ 1.6 ϫ 10 Ϫ3 g/CFU, respectively (P Ͻ 0.001). The average capsule thicknesses in minimal media with and without 10 M FeEDTA were 3.2 Ϯ 1.1 m and 8.6 Ϯ 1.9 m, respectively (P Ͻ 0.001). In contrast, no differences in capsule thickness were observed when strain 24067 cells were grown in Dulbecco modified Eagle medium with various concentrations of NaHCO 3 Ϫ and 5% CO 2 (data not shown). (15) . Since mice were infected intratracheally, we considered the possibility that the difference in capsule thickness reflected preferential extrapulmonary dissemination of cells with smaller capsules. However, when single colonies were recovered from the brain and reintroduced into mouse lung, organisms with significantly larger capsules were recovered from lung homogenates compared with brain homogenates. Furthermore, single colonies recovered from lung homogenates and reintroduced into mouse lungs disseminated, and the capsules of C. neoformans cells in brain homogenates were small. The difference in size was unlikely to reflect an artifactual effect of homogenate products on capsule thickness, because capsule thickness did not change when C. neoformans cells were suspended and grown in brain and lung homogenates. The murine immune response did not appear to influence capsule thickness, since organisms from infected SCID/ NCr and BALB/c mice had similar capsule thickness differences between brain and lung homogenates. Thus, the differences in capsule thickness are significant and reflect growth conditions in the lung and the brain. (4/3r 3 ) and area (r 2 ) were determined. Capsule thickness and volume were determined by subtracting the diameter and volume of the cell body from total cell diameter and volume.
Comparison of C. neoformans
cells from media under in vitro conditions and from organ homogenates revealed large differences in capsule thickness. The capsule thicknesses of cells grown in media were consistently smaller than those of cells recovered from lung and brain homogenates. Capsule thickness changes were reversible in that cells recovered from organ homogenates and grown in media reverted to cells with smaller capsules. Similarly, transfer of cells from media to in vivo conditions by infecting mice reproducibly resulted in cells with larger capsules, confirming the classic study of Littman in the late 1950s
FIG. 2.
Capsule thickness of yeast cells isolated from lung and brain tissues of infected mice. Bars denote average capsule thicknesses from organisms isolated from lung and brain tissues. Error bars denote standard deviations. The differences between organisms isolated from lung and brain homogenate were seen in each of the seven mice analyzed. For each measurement, the numbers of organisms analyzed ranged from 6 to 29 from brain homogenate and from 12 to 17 from lung homogenate. P 1 Ͻ 0.001 for comparison of capsule thicknesses from brain and lung isolates with that of in vitro-grown isolate ATCC 24067; P 2 Ͻ 0.001 for comparison between capsule thicknesses from brain and lung isolates.
The mechanism responsible for the differences in capsule thickness for cells in lung and brain is unknown. Phenotypic variation has been described for C. neoformans and is accompanied by changes in multiple cellular characteristics, including capsule thickness and cell size (10) . The observation that growth in media with a high iron concentration resulted in cells with smaller capsules may be relevant to this effect, since the concentration of iron in brain tissue is greater than that in lung tissue (8, 17) . In contrast, CO 2 is less likely to be a factor, since the capsule thickness of our strain was not affected by HCO 3 Ϫ / CO 2 and the concentrations of CO 2 in brain and lung tissues are equivalent (12) . Enhanced shedding of polysaccharide in brain tissue is suggested by the observation that the level of soluble GXM in brain tissue was greater than that in lung tissue. However, the possibility remains that the quantitative differences in soluble GXM reflect various abilities of the host FIG. 3 . Indirect immunofluorescence and India ink staining of representative C. neoformans cells grown in vitro (a) and isolated from lung (b) and brain (c) tissues of infected mice. Organ suspensions were stained with India ink (left panels), 1% Uvitex 3BSA (center panels), and 50 g of IgG1 MAb 2H1 per ml (right panels). Scale bar (10 m) applies to all panels.
to clear polysaccharide from the brain and lung. At this time, we cannot distinguish whether the observed phenotypic switch resulted from organ-related nutritional differences or enhanced GXM shedding. Furthermore, these findings were obtained with C. neoformans ATCC 24067, and future work is needed to establish whether the same phenomenon occurs with other strains. Nevertheless, organ-related differences in capsule thickness imply variation in capsule gene regulation in the two organs. J.R. was supported by the MARC fellowship IF-1GM18951; A.C. was supported by NIH grants AI-22274, AI-13342, and HL 59842-01 and by the Burroughs Wellcome Developmental Therapeutic award; M.F. was supported by NIH grant KO8 AI-01341; M.C. was supported by the Analytical Imaging Facility. This support is gratefully acknowledged.
